<?xml version='1.0' encoding='utf8'?><data><item><title>Em 3 meses, surtos da doença mão-pé-boca superam todo o ano de 2022 em BH</title><link>https://www.otempo.com.br/cidades/em-3-meses-surtos-da-doenca-mao-pe-boca-superam-todo-o-ano-de-2022-em-bh-1.2840049</link><ns0keywords>belo horizonte,sintomas,minas gerais,crianças,surtos da doença,febre,lesões,doença mão-pé-boca superam,2022 em bh,erupções,comum,casos</ns0keywords><pubDate>Thu, 30 Mar 2023 13:39:00 +0200</pubDate><guid isPermaLink="false">otempo-f273fcfeb39eaefb10746ff323122f6d</guid><source country="BR" url="https://www.otempo.com.br/cmlink/cidades-1.650234">otempo</source><ns1language>pt</ns1language><category ns0trigger="Coxsackie[2]; ">CoxsackieInfection</category><category>vaccination_gen</category><category>Food</category><category>Encephalitis</category><category>MedicinalXucts</category><georss>-34.37589 -55.23771</georss></item><item><title>Belo Horizonte já registrou 13 surtos da doença mão-pé-boca somente neste ano</title><link>https://www.otempo.com.br/cidades/belo-horizonte-ja-registrou-13-surtos-da-doenca-mao-pe-boca-somente-neste-ano-1.2840049</link><ns0keywords>belo horizonte,sintomas,minas gerais,crianças,surtos da doença,registrou 13 surtos,lesões,febre,horizonte já registrou,comum,doença mão-pé-boca somente,casos</ns0keywords><pubDate>Thu, 30 Mar 2023 12:05:00 +0200</pubDate><guid isPermaLink="false">otempo-b6c6bbb014f327207541629447077a8d</guid><source country="BR" url="https://www.otempo.com.br/cmlink/cidades-1.650234">otempo</source><ns1language>pt</ns1language><category ns0trigger="Coxsackie[2]; ">CoxsackieInfection</category><category>vaccination_gen</category><category>Food</category><category>Encephalitis</category><category>MedicinalXucts</category><georss>-19.92083 -43.93778</georss></item><item><title>Antibiotics, Vol. 12, Pages 665: Anti-COVID-19 Credentials of Chitosan Composites and Derivatives: Future Scope?</title><link>https://www.mdpi.com/2079-6382/12/4/665</link><ns0keywords>chitosan,virus,viral,al,derivatives,cells,sulfated,sulphate substitution,antiviral activity,kda,host cell</ns0keywords><pubDate>Tue, 28 Mar 2023 15:14:00 +0200</pubDate><guid isPermaLink="false">mdpi-9476a8e8da868b11d3c39fa69ff0caeb</guid><source country="CH" url="https://www.mdpi.com/rss">mdpi</source><ns1language>en</ns1language><category>HepatitisA</category><category>Methyl</category><category>vaccination_gen</category><category>STD</category><category>CoronavirusInfection</category><category>GM_animals</category><category>Herpes</category><category>AIDS-HIV</category><category>SwineFlu</category><category>Influenza</category><category>RiftValleyFever</category><category>Sodium</category><category>Bromine</category><category>HPV</category><category>HerpesSimplexVirus</category><category>Heparin</category><category>H7N9</category><category>Antiviral</category><category>Anticoagulant</category><category>Coccidioidomycosis</category><category ns0trigger="Coxsackievirus[1]; coxsackie[3]; ">CoxsackieInfection</category><category>VaccinationAdverseEffects</category><ns0entity id="149195" name="Rift valley">Rift Valley</ns0entity><georss>16.27167 -0.04472</georss></item><item><title>Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system</title><link>https://www.sciencedirect.com/science/article/pii/S0168170223000631?dgcid=rss_sd_all</link><ns0keywords>cell culture system,immunological characterization,easily propagated,serum-free hek293a cell,hek293a cell culture,propagation and immunological,hfmd,coxsackievirus a10,particles,characterization of coxsackievirus,study,vaccine</ns0keywords><pubDate>Sun, 26 Mar 2023 00:21:00 +0100</pubDate><guid isPermaLink="false">sciencedirect-virus-research-70cf9acd45860a17c67aa805c66a06b9</guid><source country="GB" url="http://rss.sciencedirect.com/publication/science/01681702">sciencedirect-virus-research</source><ns1language>en</ns1language><category ns0trigger="Coxsackievirus[1]; coxsackievirus[2]; ">CoxsackieInfection</category><category>Footandmouthdisease</category></item><item><title>Bostonka: Co to za choroba? Objawy u dzieci i dorosłych. Leczenie</title><link>https://wydarzenia.interia.pl/nauka/news-bostonka-co-to-za-choroba-objawy-u-dzieci-i-doroslych-leczen,nId,6309563</link><ns0keywords>bostonka,choroba,przebieg,objawy u dzieci,jamie ustnej,wirus rsv,dzieci i dorosłych,najczęściej,przypadku,niejedyne dolegliwości,osób dorosłych</ns0keywords><pubDate>Fri, 24 Mar 2023 15:34:00 +0100</pubDate><guid isPermaLink="false">interia-3b6c80de938f744c9c5377438961d071</guid><source country="PL" url="http://fakty.interia.pl/feed">interia</source><ns1language>pl</ns1language><category ns0trigger="Coxsackie[1]; wirusa Coxsackie[1]; ">CoxsackieInfection</category><category>RespiratorySyncytialVirusInfection</category><category>Vomiting</category><category>vaccination_gen</category><ns0entity id="2126739" name="Instagram Post">Instagram Post</ns0entity><georss>53.18091 17.08353</georss></item><item><title>Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates</title><link>https://www.streetinsider.com/Globe+Newswire/Oncorus+Reports+Fourth+Quarter+and+Full+Year+2022+Financial+Results+and+Provides+Business+Updates/21413767.html</link><ns0keywords>self-amplifying rna platform,oncorus reports fourth,2022 financial results,year 2022 financial,quarter ended december,quarter and full,iv-administered rna medicines,full year 2022,forward-looking statements,fourth quarter,business updates,nature communications support,product</ns0keywords><pubDate>Fri, 24 Mar 2023 12:32:00 +0100</pubDate><guid isPermaLink="false">streetinsider-989747068aaccc0f44f253e62b572c36</guid><source country="US" url="https://www.streetinsider.com/Press+Releases">streetinsider</source><ns1language>en</ns1language><category ns0trigger="Coxsackievirus[2]; ">CoxsackieInfection</category><ns0entity id="1786077" name="Nature Communications">Nature Communications</ns0entity><ns0entity id="3158571" name="Financial Results and Provides Business">Financial Results and Provides Business</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>31.70601 -83.65322</georss></item><item><title>Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates</title><link>https://www.eagletribune.com/region/oncorus-reports-fourth-quarter-and-full-year-2022-financial-results-and-provides-business-updates/article_826f735c-94a7-5736-9921-08e61fbab9ba.html</link><ns0keywords>self-amplifying rna platform,oncorus reports fourth,2022 financial results,year 2022 financial,quarter ended december,quarter and full,iv-administered rna medicines,full year 2022,forward-looking statements,fourth quarter,business updates,nature communications support,product</ns0keywords><pubDate>Fri, 24 Mar 2023 12:19:00 +0100</pubDate><guid isPermaLink="false">eagletribune-3f1ffe73869c907a3a55261ddefacc74</guid><source country="US" url="http://www.eagletribune.com/search/?f=rss&amp;t=article&amp;c=&amp;l=50&amp;s=start_time&amp;sd=desc">eagletribune</source><ns1language>en</ns1language><category ns0trigger="Coxsackievirus[2]; ">CoxsackieInfection</category><ns0entity id="1786077" name="Nature Communications">Nature Communications</ns0entity><ns0entity id="3158571" name="Financial Results and Provides Business">Financial Results and Provides Business</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>31.70601 -83.65322</georss></item><item><title>Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates</title><link>https://www.wallstreet-online.de/nachricht/16724062-oncorus-reports-fourth-quarter-and-full-year-2022-financial-results-and-provides-business-updates</link><ns0keywords>self-amplifying rna platform,oncorus reports fourth,2022 financial results,year 2022 financial,quarter ended december,quarter and full,iv-administered rna medicines,full year 2022,forward-looking statements,fourth quarter,business updates,nature communications support,product</ns0keywords><pubDate>Fri, 24 Mar 2023 12:16:00 +0100</pubDate><guid isPermaLink="false">wallstreet-online-c85b5faacb3286a89b1549fd9576cacd</guid><source country="DE" url="https://www.wallstreet-online.de/rss/nachrichten-weitere-nachrichten.xml">wallstreet-online</source><ns1language>en</ns1language><category ns0trigger="Coxsackievirus[2]; ">CoxsackieInfection</category><ns0entity id="1786077" name="Nature Communications">Nature Communications</ns0entity><ns0entity id="3158571" name="Financial Results and Provides Business">Financial Results and Provides Business</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>-38.05916 145.40947</georss></item><item><title>Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates</title><link>https://www.marketscreener.com/quote/stock/ONCORUS-INC-113170571/news/Oncorus-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Business-Updates-43329763/</link><ns0keywords>self-amplifying rna platform,oncorus reports fourth,2022 financial results,year 2022 financial,quarter ended december,quarter and full,iv-administered rna medicines,full year 2022,forward-looking statements,fourth quarter,business updates,million,product</ns0keywords><pubDate>Fri, 24 Mar 2023 12:02:00 +0100</pubDate><guid isPermaLink="false">4-traders-139ba0b3c5f294ef5815fd9ea176584d</guid><source country="FR" url="https://www.marketscreener.com/rss/FeedNews.php">4-traders</source><ns1language>en</ns1language><category ns0trigger="Coxsackievirus[2]; ">CoxsackieInfection</category><ns0entity id="1786077" name="Nature Communications">Nature Communications</ns0entity><ns0entity id="3158571" name="Financial Results and Provides Business">Financial Results and Provides Business</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>-38.05916 145.40947</georss></item><item><title>Coxsackievirus Diagnostic Testing Market Analysis 2023: Promising Growth Opportunities, Increasing Trends, Product Types, and Forecast to 2030|Agilent Technologies, Applied Gene Technologies</title><link>https://www.openpr.com/news/2988019/coxsackievirus-diagnostic-testing-market-analysis-2023</link><ns0keywords>coxsackievirus diagnostic testing,promising growth opportunities,testing market report,diagnostic testing market,applied gene technologies,increasing trends,labs regional coxsackievirus,testing market analysis,stratagem market insights,market analysis 2023,product types,sample report copy</ns0keywords><pubDate>Fri, 24 Mar 2023 09:45:00 +0100</pubDate><guid isPermaLink="false">openpr-fc1af125dd2334239e3029e060e7bd93</guid><source country="DE" url="https://www.openpr.com/rss.xml">openpr</source><ns1language>en</ns1language><category>invitrodiagnosticdevices</category><category ns0trigger="Coxsackievirus[18]; ">CoxsackieInfection</category><ns0entity id="2476229" name="Becton Dickinson">Becton Dickinson</ns0entity><ns0entity id="981471" name="Fujifilm">Fujifilm</ns0entity><ns0entity id="2332737" name="Enzo Biochem">Enzo Biochem</ns0entity><ns0entity id="2687931" name="America United">America (United</ns0entity><ns0entity id="119213" name="Agilent Technologies">Agilent Technologies</ns0entity><ns0entity id="2608907" name="Beckman Coulter">Beckman Coulter</ns0entity><ns0entity id="2409720" name="North America United">North America (United</ns0entity><georss>35.78944 139.62333</georss></item><item><title>Ce trebuie să știi despre boala gură mână picior</title><link>https://www.igj.ro/sanatate/ce-trebuie-sa-stii-despre-boala-gura-mana-picior.html</link><ns0keywords>gură mână picior,despre boala gură,trebuie să știi,boala gură mână,știi despre boala,bolii,infectate,virală,contact,virus,pielea și mucoasele,direct,persoane</ns0keywords><pubDate>Thu, 23 Mar 2023 11:55:00 +0100</pubDate><guid isPermaLink="false">impactingorj-873c4bd0bbbaace28008c40b62aacf8f</guid><source country="RO" url="https://www.igj.ro/">impactingorj</source><ns1language>ro</ns1language><category>ViralEncephalitis</category><category ns0trigger="Coxsackie[2]; coxsackievirus[1]; ">CoxsackieInfection</category><category>Encephalitis</category><category>Footandmouthdisease</category><category>Pathogen-of-war</category><category>Food</category><category>Emergingdisease</category><georss>1.28967 103.85007</georss></item><item><title>Pharmaceutics, Vol. 15, Pages 1028: Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9</title><link>https://www.mdpi.com/1999-4923/15/3/1028</link><ns0keywords>vol,mechanisms of n-phenyl,pharmaceutics,pages 1028,compounds,n-phenyl benzamides,effective,coxsackie virus a9,benzamides on coxsackie,hydrophobic pocket,antiviral mechanisms,viruses infecting humans</ns0keywords><pubDate>Wed, 22 Mar 2023 18:00:00 +0100</pubDate><guid isPermaLink="false">mdpi-83f1b21084f3d00cd694419fea186cd9</guid><source country="CH" url="https://www.mdpi.com/rss">mdpi</source><ns1language>en</ns1language><category ns0trigger="Coxsackie[1]; Coxsackieviruses[1]; ">CoxsackieInfection</category><category>Antiviral</category></item><item><title>Feed di pesce dell’acquario Approfondimenti di mercato e driver di crescita, dimensioni del settore e previsioni di analisi delle quote fino al 2028</title><link>http://digitalesiciliana.com/2023/03/21/feed-di-pesce-dellacquario-approfondimenti-di-mercato-e-driver-di-crescita-dimensioni-del-settore-e-previsioni-di-analisi-delle-quote-fino-al-2028/</link><ns0keywords>rapporto,mercato feed,market,feed di pesce,fornisce,ottieni un pdf,pesce dell'acquario approfondimenti,pdf di esempio,mercato e driver,future,driver di crescita</ns0keywords><pubDate>Mon, 20 Mar 2023 22:40:00 +0100</pubDate><guid isPermaLink="false">digitalesiciliana-305582995ec6b4fa45330139cd384538</guid><source country="IT" url="http://digitalesiciliana.com/">digitalesiciliana</source><ns1language>it</ns1language><category ns0trigger="Coxsackie[1]; coxsackie-virus-a16-nucleic-acid-detection-reagent-market-2023-key-statistics-and-consumer-buying-behaviour-by-2029-2023-03-08[1]; ">CoxsackieInfection</category><category>Dimethylethyl</category><category>CoronavirusInfection</category><ns0entity id="2569271" name="Platform Market">Platform Market</ns0entity><ns0entity id="2399333" name="Star International">Star International</ns0entity><ns0entity id="2044780" name="Wireless Network">Wireless Network</ns0entity><ns0entity id="264531" name="Microsoft">Microsoft</ns0entity><ns0entity id="2530623" name="Devices Market">Devices Market</ns0entity><ns0entity id="2816064" name="Ocean Star">Ocean Star</ns0entity><ns0entity id="2575084" name="Treatment Market">Treatment Market</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2591753" name="Equipment Market">Equipment Market</ns0entity><georss>40.71612 14.94010</georss></item><item><title>Cik reižu gadā slimot ir normāli pieaugušam cilvēkam? Uz šo un citiem jautājumiem atbild ģimenes ārste</title><link>https://jauns.lv/raksts/par-veselibu/550084-cik-reizu-gada-slimot-ir-normali-pieaugusam-cilvekam-uz-so-un-citiem-jautajumiem-atbild-gimenes-arste</link><ns0keywords>nav,vīrusu,saaukstēšanās,reižu gadā slimot,normāli pieaugušam cilvēkam,cik reižu gadā,vīrusiem,to,savu,slimot ir normāli,laikā,tas,vīrusi,būtu,simptomi</ns0keywords><pubDate>Mon, 20 Mar 2023 06:16:00 +0100</pubDate><guid isPermaLink="false">kasjauns-070dafbda2a3ad4bedf4592827ffad58</guid><source country="LV" url="https://jauns.lv/rss">kasjauns</source><ns1language>lv</ns1language><category ns0trigger="enterovīrusi[2]; ">CoxsackieInfection</category><category>AIDS-HIV</category></item><item><title>Epidemic Characterization of Hand, Foot, and Mouth Disease in Jiaxing City, China</title><link>https://www.researchsquare.com/article/rs-2685678/v1</link><ns0keywords>mouth disease,jiaxing city,foot,china,analysis,strains,hfmd,genetic,epidemic characterization,infect dis,characterization of hand,samples</ns0keywords><pubDate>Thu, 16 Mar 2023 19:37:00 +0100</pubDate><guid isPermaLink="false">researchsquare-e7b3799787e4839b7beeeb50127156b6</guid><source country="US" url="https://www.researchsquare.com/browse">researchsquare</source><ns1language>en</ns1language><category ns0trigger="Coxsackievirus[6]; coxsackievirus[2]; coxsackieviruses[1]; ">CoxsackieInfection</category><category>UGM</category><category>Epidemic</category><category>Footandmouthdisease</category><ns0entity id="2252084" name="Centers for Disease Control">Center for Disease Control</ns0entity><ns0entity id="3266486" name="Yan Song">YAN, SONG</ns0entity><ns0entity id="678690" name="Centers for Disease Control and Prevention">Center for Disease Control and Prevention</ns0entity><georss>30.75220 120.75000</georss></item><item><title>Pharmaceuticals, Vol. 16, Pages 429: Design, Synthesis, and Antiviral Activities of New Benzotriazole-Based Derivatives</title><link>https://www.mdpi.com/1424-8247/16/3/429</link><ns0keywords>cells,derivatives,pharmaceuticals,virus,atcc,human,compound 18e,apoptosis,antiviral activity,paola corona,cell,vol,strain</ns0keywords><pubDate>Sat, 11 Mar 2023 08:35:00 +0100</pubDate><guid isPermaLink="false">mdpi-0569ae0459b3f12c701d8b449ac7a914</guid><source country="CH" url="https://www.mdpi.com/rss">mdpi</source><ns1language>en</ns1language><category>Dimethylethyl</category><category ns0trigger="Coxsackievirus[1]; coxsackie[1]; ">CoxsackieInfection</category><category>Influenza</category><category>Antiviral</category><category>RespiratorySyncytialVirusInfection</category><category>SwineFlu</category><category>AIDS-HIV</category><category>H2N2</category><category>YellowFever</category><category>Communicabledisease</category><category>MERS</category><category>SARS</category><category>Vesicularstomatitis</category><category>RespiratorySyndrome</category><category>EbolaHemorrhagicFever</category><category>Methyl</category><category>HerpesSimplexVirus</category><category>CoronavirusInfection</category><category>Herpes</category><category>WHO</category><ns0entity id="1648267" name="Life Technologies">Life Technologies</ns0entity><ns0entity id="22487" name="World Health Organization">World Health Organization</ns0entity><ns0entity id="22487" name="World Health Organization">WHO</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2608907" name="Beckman Coulter">Beckman Coulter</ns0entity><georss>22.27832 114.17469</georss></item><item><title>Случаев инфицирования белорусских туристов вирусом Коксаки не зарегистрировано</title><link>https://www.tvr.by/news/obshchestvo/sluchaev_infitsirovaniya_belorusskikh_turistov_virusom_koksaki_ne_zaregistrirovano/</link><ns0keywords>случаев инфицирования белорусских,коксаки не зарегистрировано,рнпц эпидемиологии,туристов вирусом коксаки,инфицирования белорусских туристов,специалисты,белорусских туристов вирусом,эпидемиологии и микробиологии,минздрав этой страны,турции,сообщили в рнпц</ns0keywords><pubDate>Fri, 10 Mar 2023 18:11:00 +0100</pubDate><guid isPermaLink="false">tvr-ru-d36d1b129a0d1bf0bfb614f679031840</guid><source country="BY" url="https://www.tvr.by/news/">tvr-ru</source><ns1language>ru</ns1language><category>Epidemic</category><category ns0trigger="вирусом Коксаки[2]; Коксаки[2]; ">CoxsackieInfection</category></item><item><title>NISU MORBILE, ali imaju SLIČNU KLINIČKU SLIKU! Ovo oboljenje najviše pogađa decu do pet godina, a evo kako ga tačno prepoznati!</title><link>https://www.prva.rs/zivot/zdravlje/nisu-morbile-ali-imaju-slicnu-klinicku-sliku-ovo-oboljenje-najvise-pogada-decu-do-pet-godina-a-evo-kako-ga-tacno-prepoznati-2300533</link><ns0keywords>najviše pogađa decu,sličnu kliničku sliku,tačno prepoznati,pandemija korona virusa,ruku,pamet jesu morbile,oboljenje najviše pogađa,svest o higijeni,koksaki virus,sonja giljača,a evo,povećanu svest o,oboljenju,reč</ns0keywords><pubDate>Fri, 10 Mar 2023 09:31:00 +0100</pubDate><guid isPermaLink="false">prva-f72cfe976b5574b827d6f08dc422d658</guid><source country="ME" url="https://www.prva.rs/">prva</source><ns1language>bs</ns1language><category>Epidemic</category><category>Footandmouthdisease</category><category ns0trigger="Koksaki virus[1]; koksaki virus[1]; ">CoxsackieInfection</category></item><item><title>IJMS, Vol. 24, Pages 5309: Macrophage-Specific Coxsackievirus and Adenovirus Receptor Deletion Enhances Macrophage M1 Polarity in CVB3-Induced Myocarditis</title><link>https://www.mdpi.com/1422-0067/24/6/5309</link><ns0keywords>car,ijms,mice,macrophages,cvb3 infection,expression,increased,virus,macrophage m1 polarity,cvb3-induced myocarditis,adenovirus receptor,vol</ns0keywords><pubDate>Fri, 10 Mar 2023 08:54:00 +0100</pubDate><guid isPermaLink="false">mdpi-9dfa576f74afb2c88116e16b8a99655e</guid><source country="CH" url="https://www.mdpi.com/rss">mdpi</source><ns1language>en</ns1language><category ns0trigger="Coxsackievirus[1]; coxsackievirus[3]; ">CoxsackieInfection</category><category>GMO-environment</category></item><item><title>Highpoints del mercato Software di gestione della fatturazione dei consumatori 2023: crescita regionale e prognosi per il 2027</title><link>http://digitalesiciliana.com/2023/03/08/highpoints-del-mercato-software-di-gestione-della-fatturazione-dei-consumatori-2023-crescita-regionale-e-prognosi-per-il-2027/</link><ns0keywords>gestione della fatturazione,software di gestione,fatturazione dei consumatori,rapporto,market,mercato software,summary,highpoints del mercato,global top software,crescita del mercato,consumatori 2023,regione</ns0keywords><pubDate>Wed, 08 Mar 2023 15:04:00 +0100</pubDate><guid isPermaLink="false">digitalesiciliana-9d332264b1265f35445480ba4695cb5a</guid><source country="IT" url="http://digitalesiciliana.com/">digitalesiciliana</source><ns1language>it</ns1language><category>CoronavirusInfection</category><category ns0trigger="Coxsackie[1]; coxsackie-virus-a16-nucleic-acid-detection-reagent-market-2023-key-statistics-and-consumer-buying-behaviour-by-2029-2023-03-08[1]; ">CoxsackieInfection</category><category>orthopaedicdevices</category><ns0entity id="2569271" name="Platform Market">Platform Market</ns0entity><ns0entity id="2284835" name="Event Management">Event Management</ns0entity><ns0entity id="2529092" name="Delivery System">Delivery System</ns0entity><ns0entity id="2568861" name="Pipe Market">Pipe Market</ns0entity><ns0entity id="2408799" name="Global Military">Global Military</ns0entity><ns0entity id="2528522" name="Coronavirus">Covid</ns0entity><ns0entity id="2528522" name="Coronavirus">Covid 19</ns0entity><ns0entity id="2528522" name="Coronavirus">Covid-19</ns0entity><ns0entity id="2416585" name="Global Market">Global Market</ns0entity><ns0entity id="2591753" name="Equipment Market">Equipment Market</ns0entity><georss>40.38897 -3.74569</georss></item><item><title>Coxsackievirus Infections Treatment Market Growth, Share, Regional Prospects, Opportunities and Forecast 2023-2029</title><link>https://www.openpr.com/news/2966208/coxsackievirus-infections-treatment-market-growth-share</link><ns0keywords>coxsackievirus infections treatment,treatment research report,regional prospects,analysis,infections treatment market,treatment market growth,south america,east and africa,pharmacies online pharmacies,infections treatment research,share</ns0keywords><pubDate>Wed, 08 Mar 2023 13:16:00 +0100</pubDate><guid isPermaLink="false">openpr-3f12f550179ef8fa9bd7f9fb6bdb5df6</guid><source country="DE" url="https://www.openpr.com/rss.xml">openpr</source><ns1language>en</ns1language><category>CoronavirusInfection</category><category>Antiviral</category><category ns0trigger="Coxsackievirus[6]; ">CoxsackieInfection</category><ns0entity id="1158547" name="Thermo Fisher Scientific">Thermo Fisher Scientific</ns0entity><ns0entity id="274599" name="Takeda Pharmaceutical">Takeda Pharmaceutical</ns0entity><ns0entity id="322433" name="GlaxoSmithKline">GlaxoSmithKline</ns0entity><ns0entity id="1682846" name="Thermo Fisher">Thermo Fisher</ns0entity><ns0entity id="2575084" name="Treatment Market">Treatment Market</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><georss>38.89511 -77.03637</georss></item><item><title>Highly sensitive and rapid identification of coxsackievirus A16 based on reverse transcription multiple cross displacement amplification combined with nanoparticle-based lateral flow biosensor assay</title><link>https://www.frontiersin.org/articles/10.3389/fmicb.2023.1121930/full</link><ns0keywords>transcription multiple cross,guizhou medical university,cross displacement amplification,sensitive and rapid,highly,guizhou provincial centre,bacterial infectious disease,environmental pollution monitoring,reverse transcription multiple,lateral flow biosensor,basic medical sciences,rapid identification,nanoparticle-based lateral flow,guiyang,displacement amplification combined</ns0keywords><pubDate>Wed, 08 Mar 2023 05:15:00 +0100</pubDate><guid isPermaLink="false">frontiersin-microbiology-3fd01570ce298193f51bb485a0b26585</guid><source country="CH" url="https://www.frontiersin.org/journals/microbiology/rss">frontiersin-microbiology</source><ns1language>en</ns1language><category>Footandmouthdisease</category><category>Antiviral</category><category ns0trigger="coxsackievirus[2]; ">CoxsackieInfection</category><ns0entity id="44260" name="Education Ministry">Ministry of Education</ns0entity><ns0entity id="2095064" name="Key Laboratory">Key Laboratory</ns0entity><ns0entity id="2520220" name="School of Public Health">School of Public Health</ns0entity><ns0entity id="2029841" name="Clinical Laboratory">Clinical Laboratory</ns0entity><georss>26.58333 106.71667</georss></item><item><title>13:29 ZA OVAJ VIRUS RODITELJI U PRVI MAH POMISLE DA SU MORBILE! Evo kako se leči i koji su SIMPTOMI</title><link>https://informer.rs/vesti/drustvo/776550/koksaki-virus-kako-leci-koji-simptomi</link><ns0keywords>mah pomisle,u prvi mah,simptomi koksaki virusa,usta,virus roditelji u,mnogi roditelji,bolest prljavih ruku,milićević,leči i,terapija,tabanima,upravo dobilo morbile</ns0keywords><pubDate>Tue, 07 Mar 2023 13:38:00 +0100</pubDate><guid isPermaLink="false">informer-fc2d89aad1e99ee51206ddd093e38bac</guid><source country="RS" url="https://informer.rs/">informer</source><ns1language>bs</ns1language><category>Vomiting</category><category ns0trigger="koksaki virus[2]; ">CoxsackieInfection</category></item><item><title>Wild Thruway Chase With Hudson Valley Driver Ends in Crashes</title><link>https://hudsonvalleypost.com/wild-thruway-chase-with-hudson-valley-driver-ends-in-crashes/</link><ns0keywords>wild thruway chase,hudson valley driver,ends in crashes,chase with hudson,valley driver ends,county sheriff's department,police,reckless endangerment,vehicle,reached exit 21b,good tires,court on april,state</ns0keywords><pubDate>Mon, 06 Mar 2023 19:08:00 +0100</pubDate><guid isPermaLink="false">hudsonvalleypost-b2bb5911de12aeea5a8d642aa15462e5</guid><source country="US" url="https://hudsonvalleypost.com/">hudsonvalleypost</source><ns1language>en</ns1language><category ns0trigger="Coxsackie[2]; ">CoxsackieInfection</category><ns0entity id="185750" name="State Police">State Police</ns0entity><georss>42.25286 -73.79096</georss></item><item><title>Identification of specific and shared epitopes at the extreme N-terminal VP1 of Coxsackievirus A4, A2 and A5 by monoclonal antibodies</title><link>https://www.sciencedirect.com/science/article/pii/S0168170223000369?dgcid=rss_sd_all</link><ns0keywords>specific and shared,identification of specific,vp1 of coxsackievirus,recently re-emerged coxsackievirus,mabs,shared epitopes,extreme n-terminal vp1,monoclonal antibodies,coxsackievirus a4,hfmd,hfmd-associated enteroviruses warrants,diagnostic reagents,a5 by monoclonal</ns0keywords><pubDate>Thu, 02 Mar 2023 13:06:00 +0100</pubDate><guid isPermaLink="false">sciencedirect-virus-research-62572e0b46d63c6dce39c4efab943739</guid><source country="GB" url="http://rss.sciencedirect.com/publication/science/01681702">sciencedirect-virus-research</source><ns1language>en</ns1language><category ns0trigger="Coxsackievirus[2]; ">CoxsackieInfection</category><category>Footandmouthdisease</category><georss>50.50301 13.63617</georss></item></data>